“I believe that emergency approval in UK is essentially the same as the EIND in the US. It is still good because it increases our international exposure and saves lives.”

I share the same interpretation of NP’s comments regarding the U.K. and leronlimab. I find it hard to believe that the U.K. would approve leronlimab as a treatment for COVID19 without any official trials in the U.K. or FDA approval of the drug first. But as you said. A trial being started in another country, especially the U.K., will bring more attention to positive results.